Internal Medicine, Nephrology · Flushing, NY
NPI
1801058490
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
39-16 Prince Street, Unit 355
Flushing, NY, 11354
Phone (718) 886-6882
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
667 services
Medicare patients, 2024
177
Average age 77
Drug cost, 2024
$3.1M
10,140 prescriptions
Company payments, 2025
$3,172
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laurel W Yap was code 90960 (esrd related services (not dialysis)), 178 times for 31 patients. In total Laurel W Yap billed 667 services in 22 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 178 | 31 | $327.29 | $58K |
| 99213 Office E&M - Established | Office | 103 | 58 | $70.61 | $7,273 |
| 90961 ESRD Related Services (not dialysis) | Office | 84 | 23 | $271.79 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 19 | $68.23 | $4,367 |
| 36415 Venipuncture Blood Collection | Office | 30 | 28 | $8.65 | $260 |
| 81003 Clinical Chemistry | Office | 25 | 23 | $2.20 | $55 |
| 99204 Office E&M - New | Office | 24 | 24 | $143.76 | $3,450 |
| 82570 Clinical Chemistry | Office | 21 | 20 | $5.08 | $107 |
| 99222 Hospital E&M - Initial | Facility | 21 | 19 | $113.43 | $2,382 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 20 | 20 | $43.87 | $877 |
| 99214 Office E&M - Established | Office | 20 | 13 | $98.89 | $1,978 |
| 99212 Office E&M - Established | Office | 17 | 13 | $38.85 | $661 |
| 96372 Injection Administration | Office | 17 | 12 | $10.08 | $171 |
| 99233 Hospital E&M - Subsequent | Facility | 13 | 12 | $102.49 | $1,332 |
By year: 2022 $118K for 829 services; 2023 $100K for 711 services; 2024 $108K for 667 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 28 | $8.65 | $260 |
| 81003 Clinical Chemistry | 25 | 23 | $2.20 | $55 |
| 82570 Clinical Chemistry | 21 | 20 | $5.08 | $107 |
Medicare prescription drug claims, 2024
In 2024, the drug Laurel W Yap prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 665 prescriptions and refills. In total Laurel W Yap wrote 10,140 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 665 | 793 | 136 | $439K |
| Finasteride Generic | 548 | 654 | 110 | $2,643 |
| Losartan Potassium Generic | 528 | 590 | 84 | $2,263 |
| Amlodipine Besylate Generic | 514 | 636 | 110 | $2,124 |
| Tamsulosin Hcl Generic | 473 | 560 | 99 | $2,871 |
| Vascepa Icosapent Ethyl | 417 | 475 | 74 | $161K |
| Calcitriol Generic | 378 | 422 | 64 | $3,943 |
| Rayaldee Calcifediol | 377 | 379 | 58 | $452K |
| Allopurinol Generic | 309 | 376 | 45 | $1,638 |
| Olmesartan Medoxomil Generic | 295 | 405 | 60 | $2,776 |
| Jardiance Empagliflozin | 265 | 292 | 61 | $170K |
| Kerendia Finerenone | 231 | 251 | 41 | $162K |
| Atorvastatin Calcium Generic | 225 | 269 | 44 | $1,107 |
| Metoprolol Succinate Generic | 218 | 272 | 43 | $1,569 |
| Doxazosin Mesylate Generic | 215 | 259 | 46 | $1,264 |
Brand drugs: 3,158 claims; generic drugs: 6,956 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laurel W Yap $3,172 ($3,172 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $451.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $451 |
| Calliditas Therapeutics US Inc. | 14 | $373 |
| Amgen Inc. AMGN | 12 | $305 |
| Akebia Therapeutics Inc AKBA | 5 | $305 |
| Vifor Pharma, Inc. | 13 | $201 |
| OPKO Pharmaceuticals, LLC | 10 | $189 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $182 |
| Mallinckrodt Hospital Products Inc. | 8 | $177 |
| Travere Therapeutics, Inc. TVTX | 3 | $174 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.